SCHEMBL6649752

SCHEMBL6649752

CC(/C=C/C(C)C(=O)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39
GABRG3 Q99928 2/20 0.39
GABRQ Q9UN88 2/20 0.39
SLC7A5 Q01650 2/20 0.38
FOLH1 Q04609 2/20 0.33
NAALAD2 Q9Y3Q0 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18168769 1.00 TP53 (0.47) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL6649754 1.00 TP53 (0.47) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL12427680 1.00 TP53 (0.47) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL10062317 0.91 TP53 (0.40) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL31161211 0.91 TP53 (0.47) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL12257191 0.86 GABRP (0.54) TP53GABRPGABRDGABRA1GABRB1
SCHEMBL15447562 0.84
SCHEMBL5411171 0.84
SCHEMBL873697 0.84
SCHEMBL5411166 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106592239-B Large-tow universal carbon fiber sizing agent, preparation method and application 中国石油化工股份有限公司 2020-09-04 CN claimed
CN-106592239-B Large-tow universal carbon fiber sizing agent, preparation method and application 中国石油化工股份有限公司 2020-09-04 CN disclosed
US-10066188-B2 Aroma chemicals BASF SE (DE) 2018-09-04 US disclosed
US-10066188-B2 Aroma chemicals BASF SE (DE) 2018-09-04 US disclosed
EP-3145905-B1 PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS BASF SE (DE) 2018-07-11 EP disclosed
EP-3110931-B1 NOVEL AROMA CHEMICALS BASF SE (DE) 2018-04-18 EP disclosed
US-9796654-B2 Process for the dimerization of activated olefins BASF SE (DE) 2017-10-24 US disclosed
US-20170107168-A1 PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS BASF SE (DE) 2017-04-20 US disclosed
EP-3145905-A1 PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS BASF SE (DE) 2017-03-29 EP disclosed
EP-3110931-A1 NOVEL AROMA CHEMICALS BASF SE (DE) 2017-01-04 EP disclosed
WO-2015177141-A1 PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS BASF SE (DE) 2015-11-26 WO disclosed
WO-2015091924-A1 NOVEL AROMA CHEMICALS BASF SE (DE) 2015-06-25 WO disclosed
WO-2015091924-A1 NOVEL AROMA CHEMICALS BASF SE (DE) 2015-06-25 WO disclosed
US-6828464-B2 Preparation of cyclopentenones BASF AKTIENGESELLSCHAFT (DE) 2004-12-07 US disclosed
US-20040102655-A1 Preparation of cyclopentenoes BASF AKTIENGESELLSCHAFT (DE) 2004-05-27 US disclosed
EP-1422212-A1 Process for preparing cyclopentenone BASF AKTIENGESELLSCHAFT (DE) 2004-05-26 EP disclosed
EP-0297447-B1 METHOD FOR THE PREPARATION OF 2-CYCLOPENTENONES BASF Aktiengesellschaft (DE) 1991-10-16 EP disclosed
EP-0297447-A2 Method for the preparation of 2-cyclopentenones BASF Aktiengesellschaft (DE) 1989-01-04 EP disclosed
US-4502976-A BIOERODIBLE HYDROGELS BEND RESEARCH, INC. (US) 1985-03-05 US disclosed
EP-0113505-A1 Water-soluble polyesters BEND RESEARCH, INC. (US) 1984-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102655-A1 Preparation of cyclopentenoes CYP17A1, CYP2F1, CYP2S1 TP53 4796/4885GABRP 4653/4885GABRD 4413/4885
US-20170107168-A1 PROCESS FOR THE DIMERIZATION OF ACTIVATED OLEFINS AOC2, CYP1A2, OXER1 TP53 3695/4885GABRP 1417/4885GABRD 2627/4885
US-10066188-B2 Aroma chemicals SRD5A2, SRD5A1, SCD5 TP53 2270/4885GABRP 2074/4885GABRD 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.